Department of Communication Studies, San José State University, 220 E San Fernando Street, San Jose, CA, 95112, USA.
VA Palo Alto Health Care System, Center for Innovation to Implementation (Ci2i), 795 Willow Road, Menlo Park, CA, 94025, USA.
Support Care Cancer. 2020 Sep;28(9):4255-4262. doi: 10.1007/s00520-019-05274-2. Epub 2020 Jan 3.
Rising costs in oncology care often impact patients and families directly, making communication about costs and financial impacts of treatment crucial. Cost expenditures could offer opportunities for estimation and prediction, affording personalized conversations about financial impact. We sought to explore providers', patients', and caregivers' preferences towards implementing communication about cost, including when, how, and by whom such information might be provided.
We conducted semi-structured phone interviews with a diverse population including 12 oncology providers, 12 patients, and 8 patient caregivers (N = 32). The constant comparative method was used to identify mutually agreed upon themes.
Participant groups differed in their concerns surrounding cost communication, namely whether they want to receive this information and how such information might impact provider and patient treatment decisions. All participants agreed that oncology providers should not be leading cost conversations. Patients and caregivers identified social workers or financial advisors as most equipped to communicate about cost. Participants emphasized timely cost conversations, ideally around the time of diagnosis. Participants favored various metrics of financial impact beyond overall costs of care including disability, days lost from work, and out-of-pocket expenses.
Cost transparency should be incorporated into usual care; however, there are several challenges to making cost conversations a part of everyday practice. Patients and family members need resources related to cost to aid in decision-making and those delivering cost information should have competency in oncology, financial advisement, and patient-centered care.
肿瘤治疗费用的不断上涨往往会直接影响患者及其家庭,因此,对治疗费用及其经济影响进行沟通至关重要。成本支出可以提供估计和预测的机会,从而可以就经济影响进行个性化的对话。我们旨在探讨提供者、患者和护理人员对实施有关成本的沟通的偏好,包括何时、如何以及由谁提供此类信息。
我们对包括 12 名肿瘤学提供者、12 名患者和 8 名患者护理人员在内的不同人群进行了半结构化电话访谈(N=32)。使用恒定性比较方法来确定相互认可的主题。
各参与群体对成本沟通的关注有所不同,即他们是否希望获得此信息以及此类信息如何影响提供者和患者的治疗决策。所有参与者都认为肿瘤学提供者不应主导成本对话。患者和护理人员认为社会工作者或财务顾问最有能力就成本进行沟通。参与者强调应及时进行成本对话,理想情况下应在诊断时进行。参与者赞成除了护理总费用以外,还应考虑财务影响的各种指标,包括残疾、工作缺勤天数和自付费用。
应将成本透明度纳入常规护理中;但是,使成本对话成为日常实践的一部分存在一些挑战。患者和家庭成员需要与成本相关的资源来帮助做出决策,并且提供成本信息的人员应具备肿瘤学、财务咨询和以患者为中心的护理方面的能力。